CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

BackgroundEarly high-efficacy treatment for people with relapsing multiple sclerosis (pwRMS) may provide better long-term outcomes compared with the escalation strategy. In this study, we present an analysis of treatment success and safety from the CONFIDENCE study in a real-world cohort of pwRMS tr...

Cijeli opis

Bibliografski detalji

Glavni autori:	Mathias Buttmann, Martin S. Weber, Sven G. Meuth, Sandra Blümich, Stefanie Hieke-Schulz, Petra Dirks, Julius C. Eggebrecht, Tjalf Ziemssen
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-05-01
Serija:	Frontiers in Neurology
Teme:	Relapsing multiple sclerosis humanized monoclonal anti-CD20 antibody neurodegenerative diseases non-interventional study (NIS) ocrelizumab real-world cohort
Online pristup:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1564327/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!